NSE · SGRL
Shree Ganesh Remedies Limited (SGRL) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,687
of 5,047 stocks
▼ 221W▼ 581M
Peak #1,602 · 02 Oct 2026
Shree Ganesh Remedies Limited is a smallcap company in the Healthcare space and remains firmly promoter-controlled, with promoters holding 73%, is growing revenue modestly, and commands a premium earnings multiple.
Market Cap
792.91 Cr
P/E Ratio
44.66
P/B Ratio
4.87
ROE
10.90%
ROCE
14.83%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 23.29 Cr | 14.36 Cr | 33.20 Cr | 21.11 Cr |
| Net Profit | 1.63 Cr | 1.12 Cr | 6.27 Cr | 3.09 Cr |
| EPS | 1.27 | 0.87 | 4.88 | 2.41 |
| Operating Profit | 2.84 Cr | 1.85 Cr | 9.60 Cr | 4.72 Cr |
Shareholding pattern
Promoter
72.84%
Public
27.16%
PUBLIC BREAKDOWN
DII
0.52%
MF (within DII)
0.00%
Individuals
25.22%
Mutual fund holdings
₹0.01
Cr total
2
Schemes
2
Fund Houses
₹0.01 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.01 Cr (68.2%)
Bandhan Mutual Fund₹0.00 Cr (31.8%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
No corporate actions on record for this stock.
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.